ONE SITE AND TWO SITES PHACOTRABECULECTOMY: A COMPARATIVE STUDY
Egyptian Journal of Clinical Ophthalmology · 2018
DOI: 10.21608/ejco.2018.163052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Egyptian Journal of Clinical Ophthalmology, 2018. Verfasst von Abdelhakam und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Purpose
To compare the results of one-site versus two-site combined glaucoma filtration andphacoemulsification surgery with respect to visual acuity (VA) and intraocular pressure (IOP)control. Methodology: A prospective study was conducted on 40 patients with glaucoma andcataract. Cases will be divided into two random groups: Group A: 20 eyes were subjected to one sitePhacotrabeculectomy. Group B: 2o eyes were subjected to two-site Phacotrabeculectomy. Theresults were compared within one week, one month, three months and sex months postoperative as regards VA and IOP.
Results
There was a statistically significant difference in VAand IOP in pre-operative and post-operative conditions in the whole patients. There was nostatistically significant difference in VA and IOP post-operatively between the two groups.
Conclusion
The similar and excellent results achieved in the 2 groups imply that either techniquemight be used to handle the problem of concurrent cataract and glaucoma in many patients.
Zitieren
APA
Abdelhakam, M., badie, A. E., M., Fathy, & A. (2018). ONE SITE AND TWO SITES PHACOTRABECULECTOMY: A COMPARATIVE STUDY. Egyptian Journal of Clinical Ophthalmology. https://doi.org/10.21608/ejco.2018.163052
Vancouver
Abdelhakam, M., badie AE, M., Fathy, A.. ONE SITE AND TWO SITES PHACOTRABECULECTOMY: A COMPARATIVE STUDY. Egyptian Journal of Clinical Ophthalmology. 2018. doi:10.21608/ejco.2018.163052
BibTeX
@article{Abdelhakam2018,
author = {Abdelhakam and M. and badie, Abd El- and M. and Fathy and A.},
title = {ONE SITE AND TWO SITES PHACOTRABECULECTOMY: A COMPARATIVE STUDY},
journal = {Egyptian Journal of Clinical Ophthalmology},
year = {2018},
doi = {10.21608/ejco.2018.163052}
}
EUVIMED